Christine Huselton
Pfizer (United States)(US)
Publications by Year
Research Areas
Retinoids in leukemia and cellular processes, Estrogen and related hormone effects, Drug Transport and Resistance Mechanisms, Cholesterol and Lipid Metabolism, Antioxidant Activity and Oxidative Stress
Most-Cited Works
- → 9-Cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα(1992)1,244 cited
- Clinical pharmacology of oral all-trans retinoic acid in patients with acute promyelocytic leukemia.(1992)
- → Design, Synthesis, and SAR of New Pyrrole-Oxindole Progesterone Receptor Modulators Leading to 5-(7-Fluoro-3,3-dimethyl-2-oxo-2,3-dihydro-1H-indol-5-yl)-1-methyl-1H-pyrrole-2-carbonitrile (WAY-255348)(2008)196 cited
- → SKI-606, a Src/Abl Inhibitor withIn vivoActivity in Colon Tumor Xenograft Models(2005)134 cited
- → The Metabotropic Glutamate Receptor 7 Allosteric Modulator AMN082: A Monoaminergic Agent in Disguise?(2011)103 cited
- → Constitutive Variability in the Pharmacokinetics of the Natural Retinoid, All-trans-Retinoic Acid, and Its Modulation by Ketoconazole(1993)87 cited
- → Indazole-Based Liver X Receptor (LXR) Modulators with Maintained Atherosclerotic Lesion Reduction Activity but Diminished Stimulation of Hepatic Triglyceride Synthesis(2008)75 cited
- → 5-Piperazinyl-3-sulfonylindazoles as Potent and Selective 5-Hydroxytryptamine-6 Antagonists(2010)67 cited
- → 3-(3-Aryloxyaryl)imidazo[1,2-a]pyridine sulfones as liver X receptor agonists(2009)60 cited
- → Discovery of Phenyl Acetic Acid Substituted Quinolines as Novel Liver X Receptor Agonists for the Treatment of Atherosclerosis(2006)50 cited